4
Changes in Ownership
Telix Pharmaceuticals Ltd Filed Acc 0001628280-26-031608
MD & Group CEO bought 67,935 shares at an average $14.67 ($996,738)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Behrenbruch Christian MD & Group CEO | 2026-04-28 | Purchase | +34,500 | $14.48 | $499,560 | 20,709,500 | I |
| Behrenbruch Christian MD & Group CEO | 2026-04-29 | Purchase | +33,435 | $14.87 | $497,178 | 20,742,935 | I |
| Open-market purchases · 67,935 sh · avg $14.67 · $996,738 | |||||||
Loading xslF345X06/wk-form4_1778117523.xml…